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Abstract Ascorbic acid synthesis and breakdown were investi- 
gated in isolated hepatocytes prepared from fasted mice. 
Stimulation of gluconeogenesis by alanine or xylitol led to 
ascorbate synthesis. On the other hand, ascorbate or dehydro- 
ascorbate addition resulted in concentration-dependent glucose 
production and elevation of the pentose phosphate pathway 
intermediate xylulose 5-phosphate. Stimulation of ascorbate 
oxidation and/or the inhibition of dehydroascorbate r duction 
increased glucose formation. Inhibition of the pentose phosphate 
pathway decreased glucose production from dehydroascorbate 
with increased accumulation of xylulose 5-phosphate. These 
results suggest hat ascorbate can be recycled by a novel way 
involving intermediates of the pentose phosphate pathway, 
gluconeogenesis and hexuronic acid pathway. 
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1. Introduction 
Ascorbic acid is one of the most important water-soluble 
al~tioxidants [1]. In ascorbate-synthesising animals it is pro- 
duced through the hexuronic pathway in liver or kidney [2]. 
It~ oxidation produces dehydroascorbic acid, which can be 
ct~nverted back to ascorbate by glutathione-dependent non- 
el zymatic [1] or enzymatic reactions [3]. Since dehydroascor- 
b:.te at physiological pH is unstable with a half-life of a few 
minutes, it may be rapidly metabolised through diketogulo- 
n~.te to 5-carbon intermediates. Although the participation of 
tt~e pentose phosphate pathway in the metabolism of dehy- 
dE oascorbate has been suggested [4], its final fate has not been 
.ql defined. A minor pathway of catabolism gives oxalate 
a~d 4-carbon intermediates [4]. 
Oxidative stress results in simultaneous consumption of the 
two main antioxidants, GSH and ascorbate. In the case of 
sl ortage of GSH, since reduction of dehydroascorbate to as- 
c~,rbate is decreased, its degradation becomes the dominant 
p;Lthway, which would worsen the antioxidant state of the 
ct II. 
The aim of the present study was to investigate the further 
n-Letabolism of dehydroascorbate and the role of the pentose 
pL~osphate pathway in this process. Our results suggest hat 
a~.corbate is a gluconeogenic precursor via pentose phosphates 
ir isolated murine hepatocytes prepared from starved mice. 
This metabolic route provides substrates for ascorbate re- 
synthesis. 
2. Materials and methods 
2.1. Materials' 
Collagenase (type IV), glucose UV-visible enzymatic (hexokinase) 
determination kit, Nucleosil C18 column (average particle size 5 gM, 
250 × 4.6 mm I.D), glyceraldehyde-3-phosphate dehydrogenase from 
rabbit muscle, yeast ransketolase, ribose 5-phosphate disodium salt, 
cocarboxylase (thiamine pyrophosphate chloride), [3-nicotinamide 
adenine dinucleotide sodium salt, sodium arsenate, L-buthionine- 
(S,R)-sulfoximine, menadione and oxythiamine hydrochloride were 
purchased from Sigma (St. Louis, MO, USA). Dehydroascorbic a id 
was bought from Merck (Darmstadt, Germany). All other materials 
were of analytical grade. 
2.2. Preparation and incubation of isolated mouse hepatoeytes 
CFLP male mice (25-35 g body weight, Human, G6d6116, Hun- 
gary) fasted for 48 h were used. Isolated hepatocytes were prepared 
by the collagenase perfusion method as described earlier [5]. Hepato- 
cytes (1-2× 106 cells/ml) incubated in Krebs-Henseleit bicarbonate 
buffer (pH 7.4) containing 2.5 mM CaC12 and 1% albumin were stir- 
red by constant bubbling with gas (O2/CO2, 95:5 v/v%) at 37°C. 
Viability of the cells checked by the trypan blue exclusion test was 
about 85 95°/,,. 
2.3. Treatment of mice 
The B1 vitamin antagonist oxythiamine hydrochloride was dis- 
solved in sterile nonpyrogenic physiologic saline. The pH of this solu- 
tion was adjusted to 7.4 at 37°C. 20 mg/kg body weight thiamine 
antagonist was given intraperitoneally to 42 h starved mice in 1 ml 
final volume. Control groups of 42 h starved animals received 1 ml 
isotonic saline [6]. 
2.4. Measurement of metabolites 
Incubations were terminated by the addition of cold perchloric acid 
(PCA, 3% final concentration). Glucose was measured in the depro- 
teinised neutralised supernatants by the UV-visible hexokinase meth- 
od [7]. Ascorbic acid (reduced and total) was measured by HPLC 
following specific sample preparation as described earlier [8]. The 
GSH content of the suspension was determined from PCA-soluble 
supernatants according to [9]. The xylulose 5-phosphate l vel was 
measured in the PCA-soluble supernatants after deproteinisation 
and neutralisation by modified transketolase enzymatic assay using 
ribose 5-phosphate as other substrate beside xylulose 5-phosphate 
[lO]. 
2.5. Miscellaneous 
Cell numbers were calculated on the basis of DNA content of 
hepatocytes determined according to [11]. Statistical analysis was per- 
formed using Student's t-test. 
3. Results 
*~ 2orresponding author. Fax: (36) (1) 266 2615. 
A,breviations: BSO, buthionine sulfoximine; GSH, glutathione (re- 
duced form). 
3.1. Glucose production from ascorbate or dehydroascorbate in 
isolated mouse hepatocytes 
Hepatocytes prepared from 48 h starved animals are glyco- 
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gen depleted [12] therefore, the source of their glucose produc- 
tion is gluconeogenesis. Cells were incubated in the presence 
of various concentrations of ascorbate or dehydroascorbate 
for 30 min and their glucose production was measured. For 
comparison gluconeogenesis from alanine was also detected. 
Significant glucose formation from ascorbate was observed, 
which reached saturation at relatively low ascorbate concen- 
trations. Dehydroascorbate-fueled g ucose production showed 
a greater ate and saturation was reached at higher substrate 
concentrations. Gluconeogenesis from both substrates was 
surprisingly effective, its rate being comparable to that from 
alanine (Fig. 1). Stimulation of ascorbate oxidation to dehy- 
droascorbate by menadione increased the rate of gluconeogen- 
esis (Fig. 1). 
3.2. Effect of glutathione depletion on dehydroascorbate 
metabolism in isolated mouse hepatocytes 
Treatment of isolated hepatocytes with buthionine sulfoxi- 
mine strongly reduced the intracellular glutathione pool (data 
not shown). As expected, this treatment resulted in diminished 
GSH-dependent reduction of dehydroascorbate. At the same 
time, increased glucose production was observed while the 
consumption of added dehydroascorbate remained unaltered 
(Table 1). BSO addition did not significantly influence gluco- 
neogenesis from alanine (data not shown). 
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3.3. Role of the pentose phosphate pathway in gluconeogenesis 
from dehydroascorbate in isolated mouse hepatocytes 
Addition of dehydroascorbate resulted in an increase of 
xylulose 5-phosphate, an intermediate of the pentose phos- 
phate pathway in isolated hepatocytes (Table 2). Based on 
this observation, the possible participation of the pentose 
phosphate pathway in gluconeogenesis from ascorbate was 
supposed. This metabolic route was inhibited by in vivo ad- 
ministration of oxythiamine which is known to inhibit trans- 
ketolases [6]. In cells prepared from oxythiamine-treated 
starved animals, the addition of dehydroascorbate resulted 
in lower glucose formation and simultaneously decreased con- 
sumption of added dehydroascorbate. At the same time, the 
accumulation of xylulose 5-phosphate was greater in oxythi- 
amine-treated hepatocytes than in controls (Table 2). Oxythi- 
amine treatment did not alter gluconeogenesis from alanine 
(data not shown). 
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Fig. 1. Gluconeogenesis from ascorbate or dehydroascorbate in 
murine hepatocytes. Isolated hepatocytes prepared from 48 h 
starved mice were incubated in the presence of different concentra- 
tions of ascorbate (11), ascorbate+0.1 mM menadione (<)), dehy- 
droascorbate (D) and alanine (0). Glucose production was deter- 
mined after 30 min incubation. Data are given as means+ S.E.M., 
n=3-16. Statistically significant differences from corresponding val- 
ues gained in the presence of ascorbate: **P< 0.02, ***P < 0.01. 
tive intermediate of ascorbate catabolism [4], was also 
investigated. Similarly to alanine, addition of xylitol stimu- 
lated glucose production and ascorbate resynthesis (Table 3). 
3.4. Ascorbate synthesis from gluconeogenic precursors 
Addition of alanine, a known gluconeogenic substrate, re- 
sulted in moderate, but measurable ascorbate synthesis n iso- 
lated hepatocytes. The gluconeogenic effect of xylitol, a puta- 
4. Discussion 
Although several papers indicate the further metabolism of 
dehydroascorbate, it has usually been regarded as a waste 
Table 1 
Effect of glutathione depletion on dehydroascorbate m tabolism 
Addition Glucose production 
(nmol/min per 106 cells) 
Conversion of dehydro- 
ascorbate to ascorbate 
(nmol/min per 106 cells) 
Consumption of added 
dehydroascorbate 
(nmol/min per 10 6 cells) 
None 0.49 + 0.10 N.D. N.D. 
5 mM buthionine sulfoximine 0.79 + 0.16 N.D. N.D. 
5 mM dehydroascorbate 8.35 + 1.33 a 8.04 + 1.81 185.97 _+ 12.17 
5 mM buthionine sulfoximine + 11.64 _+ 1.16 a,b 3.44 _ 0 .81  b 162.05 + 19.09 
5 mM dehydroascorbate 
Isolated hepatocytes prepared from 48 h fasted animals were incubated in the presence or absence of 5 mM dehydroascorbate nd/or 5 mM 
buthionine sulfoximine (BSO) for 30 min. Glucose production, dehydroascorbate consumption and its conversion to ascorbate were measured. 
Values are expressed asmeans+ S.E.M., n =4-12. Significant difference from the corresponding controls: ap < 0.01, and between data obtained 
from dehydroascorbate or dehydroascorbate + BSO addition: bp < 0.05; N.D., not determined. 
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[ ~g. 2. Ascorbate cycle in mouse hepatocytes. Ascorbate oxidised to dehydroascorbate canbe recycled by a novel, glutathione-independent 
bay; intermediates of pentose phosphate pathway, the gluconeogenic sequence and hexuronic acid pathway are involved in the proposed cycle. 
"lhe treatments and additions used in the experiments are also indicated. 
product of ascorbate-consuming processes. In this study we 
show that besides the reduction of dehydroascorbate to ascor- 
bate, an alternative pathway also exists, which provides the 
possibility for ascorbate resynthesis n a roundabout way. 
It is suggested that glucose formation from ascorbate oc- 
cars via dehydroascorbate. Gluconeogenesis from ascorbate is
simulated in the presence of an oxidative agent, menadione 
(Zig. 1). GSH depletion caused by BSO inhibits the reduction 
('f dehydroascorbate to ascorbate and results in enhanced 
~'lucose production (Table 1). 
5-Carbon intermediates of ascorbate catabolism have been 
t resumed to enter the pentose phosphate pathway [4]. The 
iacrease in xylulose 5-phosphate levels in hepatocytes after 
dehydroascorbate ddition or the diminished glucose produc- 
ton  from added dehydroascorbate nd the higher xylulose 5- 
thosphate content in hepatocytes where the non-oxidative 
t'ranch of the pentose phosphate route is blocked clearly sup- 
tort  this suggestion (Table 2). Stimulated gluconeogenesis 
lrom xylitol also supports this view (Table 3). e-Pentoses 
can be converted to D-pentoses through xylitol, thus it may 
be an important intermediate of dehydroascorbate m tabo- 
lism. The intermediates of the pentose phosphate pathway 
finally can enter the gluconeogenic sequence yielding glucose 
6-phosphate and glucose. Glucose 6-phosphate is a precursor 
of ascorbate synthesis in the hexuronic pathway. Both ala- 
nine, as gluconeogenic precursor, and xylitol were able to 
stimulate ascorbate production in isolated hepatocytes (Table 
3). These results indicate that besides the classic GSH-depen- 
dent ascorbate recycling another - GSH-independent - 
pathway also exists in ascorbate-synthesising cells. In hepato- 
cytes ascorbate can be regenerated from dehydroascorbate in 
a cycle through the intermediates of the pentose phosphate 
pathway, gluconeogenesis and the hexuronic acid pathway 
(Fig. 2). 
This novel pathway of the ascorbate cycle may be especially 
important during starvation when major - glycogenolysis- 
dependent [12] - ascorbate synthesis and its exogenous up- 
ply are missing or in oxidative stress which favours dehy- 
'i able 2 
t ffect of inhibition of pentose phosphate pathway on gluconeogenesis from dehydroascorbate in isolated mouse hepatocytes 
reatment Addition Glucose production Consumption of added Xylulose 5-phosphate 
(nmol/min per 106 ceils) dehydroascorbate content 
(nmol/min per 106 cells) (pmol/106 cells) 
I ~otonic saline none 0.76 _+ 0.22 N.D. 21.98 _+ 10.11 
5 mM dehydroascorbate 13.33 + 1.53 b 185.97 + 12.18 184.66 + 26.17 b
( )xythiamine none 1.01 + 0.25 N.D. 162.06 + 35.09 a
5 mM dehydroascorbate 4.87 + 0.43 b,c 93.48 + 13.57 b,c 537.16 + 13.61 b'c 
~2 h starved mice received a single intraperitoneal injection of 20 mg/kg body weight oxythiamine, a known inhibitor of transketolases, in 1 ml final 
\ olume. Control animals received 1 ml of isotonic saline. 6 h later mice were sacrificed and hepatocytes were prepared from their liver. Glucose 
l,roduction, consumption of added ehydroascorbate ndxylulose 5-phosphate content were determined in both groups after 30 min of incubation 
as detailed in Section 2. Values are given as means + S.E.M., n = 3 12. Statistically significant difference from the oxythiamine untreated controls 
~p < 0.02, bp < 0.01, and in the presence of dehydroascorbate between values gained from oxythiamine treated or untreated animals ~p < 0.01; 
N.D., not determined. 
186 
Table 3 
Ascorbate synthesis from gluconeogenic precursors 
L. Braun et al.IFEBS Letters 390 (1996) 183-186 
Addition Glucose production (nmol/min per 10 6 cells) Ascorbate production (pmol/min per 10 6 cells) 
None 1.01 + 0.09 - 1.79 + 0.63 
10 mM alanine 16.24 + 3.22 ~ 1.45 _+ 0.43 ~ 
10 mM xylitol 15.96 + 1.63 a 1.57 + 0.45 ~ 
Glycogen-depleted isolated hepatocytes were incubated in the presence of alanine or xylitol for 30 min. Glucose and ascorbate production were 
measured. Data are means_+ S.E.M., n = 4. Significant difference from the corresponding controls: ~p < 0.01. 
droascorbate formation directly and by GSH depletion. This 
cycle saves dehydroascorbate for glucose production or ascor- 
bate resynthesis. 
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